Methasterone

Methasterone, also known as Superdrol or methyldrostanolone, is a synthetic steroid that was developed in the 1950s by Syntex Corporation. It is a potent anabolic steroid that is often used by bodybuilders and athletes for its ability to increase muscle mass and strength. However, it is also associated with a number of serious side effects and is currently classified as a controlled substance in many countries.

History

Methasterone was first described in a 1956 paper by researchers at Syntex Corporation, a pharmaceutical company that was also responsible for the development of other well-known steroids such as Oxymetholone and Methyldienolone. Despite its potential as an anabolic agent, Methasterone was never marketed for medical use. Instead, it was sold as a dietary supplement under the brand name Superdrol in the early 2000s.

Pharmacology

Methasterone is a synthetic and orally active anabolic–androgenic steroid (AAS) and a 17α-alkylated derivative of Drostanolone. It is a potent androgen, with more than three times the androgenic potency of Testosterone. Methasterone works by binding to and activating the Androgen receptor, leading to increased protein synthesis and muscle growth.

Side effects

The use of Methasterone is associated with a number of serious side effects, including liver damage, cardiovascular disease, and changes in mood and behavior. It can also cause a decrease in the body's natural production of testosterone, leading to symptoms such as fatigue, depression, and sexual dysfunction.

Legal status

Methasterone is classified as a controlled substance in many countries, including the United States, Canada, and the United Kingdom. It is also banned by many sports organizations, including the World Anti-Doping Agency.

See also

• Anabolic steroid
• Controlled Substances Act
• Doping in sport